Sort   by:  
 Page size 
UnknownPerivascular PDGFR-β is an independent marker for prognosis in renal cell carcinoma.
Not available
S-EPMC5243993 | biostudies-literature
UnknownTreatment and overall survival in renal cell carcinoma: a Swedish population-based study (2000-2008).
Not available
S-EPMC3629428 | biostudies-literature
UnknownPerivascular Neuropilin-1 expression is an independent marker of improved survival in renal cell carcinoma.
Not available
S-EPMC7155095 | biostudies-literature
UnknownA minority-group of renal cell cancer patients with high infiltration of CD20+B-cells is associated with poor prognosis.
Not available
S-EPMC6189087 | biostudies-literature
UnknownCellular and secretome profiling uncover immunological biomarkers in the prognosis of renal cell carcinoma patients.
Not available
S-EPMC11934188 | biostudies-literature
UnknownZoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer.
Not available
S-EPMC5593706 | biostudies-literature
UnknownBaseline laboratory values and metastatic burden predict survival in addition to IMDC risk in real-world renal cell carcinoma patients treated with ipilimumab-nivolumab.
Not available
S-EPMC12509422 | biostudies-literature
UnknownAn expression signature at diagnosis to estimate prostate cancer patients' overall survival.
Not available
S-EPMC3921673 | biostudies-literature
UnknownRenal cell carcinoma escapes NK cell-mediated immune surveillance through the downregulation of DNAM-1.
Not available
S-EPMC10354414 | biostudies-literature
UnknownNivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.
Not available
S-EPMC5719487 | biostudies-literature
Sort   by:  
 Page size